CENCIARELLI, CARLO
 Distribuzione geografica
Continente #
AS - Asia 2.204
NA - Nord America 1.604
EU - Europa 638
SA - Sud America 431
Continente sconosciuto - Info sul continente non disponibili 379
AF - Africa 34
OC - Oceania 3
Totale 5.293
Nazione #
US - Stati Uniti d'America 1.517
SG - Singapore 896
CN - Cina 497
BR - Brasile 341
IT - Italia 272
VN - Vietnam 243
HK - Hong Kong 194
FR - Francia 153
KR - Corea 95
JP - Giappone 61
BD - Bangladesh 52
IN - India 51
DE - Germania 48
FI - Finlandia 40
CA - Canada 32
GB - Regno Unito 29
NL - Olanda 27
AR - Argentina 24
CO - Colombia 21
MX - Messico 21
EC - Ecuador 19
ID - Indonesia 18
IQ - Iraq 16
RU - Federazione Russa 13
IL - Israele 12
PL - Polonia 11
PK - Pakistan 10
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
TR - Turchia 7
VE - Venezuela 7
ZA - Sudafrica 7
AT - Austria 6
EG - Egitto 6
MA - Marocco 6
PE - Perù 6
BB - Barbados 5
CR - Costa Rica 5
ES - Italia 5
MY - Malesia 5
CL - Cile 4
EE - Estonia 4
HN - Honduras 4
IE - Irlanda 4
JM - Giamaica 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
UZ - Uzbekistan 4
AU - Australia 3
DZ - Algeria 3
GT - Guatemala 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
SE - Svezia 3
UA - Ucraina 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
AO - Angola 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
PH - Filippine 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
UG - Uganda 1
Totale 4.914
Città #
Santa Clara 561
Singapore 527
Hefei 208
Hong Kong 189
Rome 156
San Jose 154
Lauterbourg 107
Ashburn 103
Beijing 101
Seoul 93
Ho Chi Minh City 82
Los Angeles 76
Hanoi 57
Tokyo 45
São Paulo 41
Frankfurt am Main 22
Dallas 18
Helsinki 17
Lappeenranta 16
Council Bluffs 15
Buffalo 14
New York 14
Brasília 13
Chennai 13
Düsseldorf 13
Houston 13
Milan 13
Orem 13
Minamishinagawa 12
Atlanta 11
Bengaluru 11
Chicago 11
Redondo Beach 11
Philadelphia 10
Biên Hòa 9
Brooklyn 9
Naples 8
Rio de Janeiro 8
Warsaw 8
Amsterdam 7
Boston 7
Haiphong 7
Turku 7
Belo Horizonte 6
Braga 6
Dhaka 6
Las Vegas 6
London 6
Montreal 6
Paris 6
Pittsburgh 6
Quito 6
Quận Bình Thạnh 6
Bridgetown 5
Curitiba 5
Da Nang 5
Goiânia 5
Guangzhou 5
Hải Dương 5
Lima 5
Medellín 5
Miami 5
Mumbai 5
Queens 5
San Valentino Torio 5
Thái Bình 5
Albany 4
Baghdad 4
Bandung 4
Bologna 4
Campinas 4
Charlotte 4
Cleveland 4
Dublin 4
Falkenstein 4
Florence 4
Istanbul 4
Kingston 4
Marion 4
Ninh Bình 4
Palermo 4
Phủ Lý 4
Pisa 4
Portsmouth 4
San Francisco 4
Stockton 4
Tashkent 4
Thái Nguyên 4
Toronto 4
Vienna 4
Blumenau 3
Bogotá 3
Brescia 3
Buenos Aires 3
Bắc Ninh 3
Bến Tre 3
Calgary 3
Can Tho 3
Canoas 3
Caracas 3
Totale 3.081
Nome #
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab 121
Gene expression Profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra 96
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer 93
Aspirin Inhibits Cancer Stem Cells properties and growth of Glioblastoma multiforme through Rb1 Pathway Modulation 92
Mechanism of induction of the Rb gene promoter by MyoD 84
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment 83
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab 82
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells 80
Brahma is required for cell cycle arrest and late muscle gene expression during skeletal myogenesis 79
Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases 75
Recent Perspective about the Amyloid Cascade Hypothesis and Stem Cell-Based Therapy for Alzheimer's Disease. 72
Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways 71
A pilot study on human Wharton s jelly mesenchymal stem cells induced to neural differentiation 70
Recent perspective on CAR and Fcgamma-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes 68
The Interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets 68
MyoD can enhance the activity of Retinoblastoma gene promoter through a CREB site 67
Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential 61
Identification of a family of human F-box proteins 59
PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment 59
PDGFR alpha depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals 59
Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth 59
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1 57
Potential of Stem Cell-Based Therapy for Ischemic Stroke 57
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. 56
EGFR and NOTCH1 signaling inhibition differently regulate cell growth and apoptosis of core and peritumoral glioblastoma stem-like cells 56
Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired 54
Gene Expression Profile of Adult Human Olfactory Bulb and Embryonic Neural Stem Cell Suggests Distinct Signaling Pathways and Epigenetic Control 54
Local therapy in glioma: An evolving paradigm from history to horizons (Review) 54
Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene 52
Over-expression of hNGF in Adult human Olfactory Bulb Neural Stem Cells promotes cell growth and oligodendrocytic differentiation. 52
Stroke in Elderly: Current Status and Future Directions - E-Book 52
p53 signaling in cancer progression and therapy 52
High Nitric Oxide production, secondary to high inducible-nitric oxide synthase expression, is essential in regulating tumor initiating properties of colon cancer stem cells. 51
Pharmacological inhibition of Notch1 and EGFR signaling differently affect cell growth and survival of core and peritumoral glioblastoma-derived stem cells 51
Human Olfactory Bulb Neural Stem Cells expressing hNGF Restore Cognitive Deficit in Alzheimer's Disease Rat Model 50
Potential of antibody-drug conjugates (ADCs) for cancer therapy 50
Forskolin promotes neuronal differentiation on human Wharton s jelly mesenchymal stem cells 49
Transcriptional control of the Htf9-A/RanBP-1 gene during the cell cycle 49
Differentiation of human olfactory bulb-derived neural stem cells towards oligodendrocyte 48
Research progress on immune microenvironment and molecular mechanism of glioma 48
Transplantation of rat embryonic neural stem cells in the rat hippocampus during trimethyltin-induced neurodegenration 47
MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway 47
Human Olfactory Bulb Neural Stem Cells Mitigate Movement Disorders in a Rat Model of Parkinson's disease. 46
Generation of gene edited hiPSC from familial Alzheimer's disease patient carrying N141I missense mutation in presenilin 2. 46
Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches 46
Inflammation in Ischemic Stroke and Novel Therapeutic Strategies for Stroke Treatment 45
Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies 45
Effects of Rosemary Oil (Rosmarinus officinalis) supplementation on the fate of the transplanted human olfactory bulb neural stem cells against ibotenic acid-induced neurotoxicity (Alzheimer model) in rat 44
In vitro analysis of mouse neural stem cells genetically modified to stably express human NGF by a novel multigenic viral expression system. 44
Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches 44
Critical Role Played by Cyclin D3 in the MyoD-Mediated Arrest of Cell Cycle during Myoblast Differentiation 44
MyoD induces RB1 gene expression in differentiating cells 43
Induction of Dopaminergic Neurons From Human Wharton's Jelly Mesenchymal Stem Cell by Forskolin 43
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme 43
Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation 43
Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors 42
Therapeutic potential of human olfactory bulb neural stem cell for spinal cord injury in rats. 42
Oncosuppressor genes in myogenic differentiation 41
Five human genes encoding F-box proteins: chromosomal mapping and analysis in human tumors. 40
Inflammation in ischemic stroke and novel therapeutics strategies for stroke treatment 40
Meccanismi di stabilizzazione della Ciclina D3 nel differenziamento miogenico 40
The mouse proliferation-asociated HTF9-A gene is a potential target of the p105/E2F complex 39
Identification and early characterization of genetically modified NGF-producing neural stem cells grafted into the injured adult rat brain 39
EGFR+ GLIOBLASTOMA STEM CELLS TARGETING BY CD16158V-CHIMERIC RECEPTOR T CELLS AND CETUXIMAB 38
The Adenovirus 5 transforming regions are required for the inhibition of MyoD transacting function 38
MYOD INDUCES RETINOBLASTOMA GENE-EXPRESSION DURING MYOGENIC DIFFERENTIATION 38
Regulation of pRb phosphorylation in differentiating myogenic cells. 37
Fate of transplanted rat embryonic neural stem cells in the rat hippocampus during trimethyltin-induced neurodegeneration 36
Identification and characterization of genetically modified NGF-producing neural stem cells injected in adult rats: a pilot study 35
Role of the retinoblastoma gene in cell differentiation 35
HTLV-1 Tax-associated hTid-1, a Human DnaJ Protein, Is a Repressor of IB Kinase Subunit 35
MyoD induces and E1A and inhibits the up-regulation of the RB1 gene expreassion during myogenic differentiation 34
Transplantation of Foetal Neural Stem Cells into the Rat Hippocampus During Trimethyltin-Induced Neurodegeneration 34
A novel mouse gene expressed in cycling cells is a potential target of the p105/E2F complex 34
Mechanism of induction of the Rb gene promoter by MyoD 34
Effects of Adenovirus E1A on regulation of RB1 gene promoter 34
Domains of E1A required for the inhibition of MyoD transcription and activity 34
Human Olfactory Bulb Neural Stem Cells expressing hNGF Restore Cognitive Deficit in Alzheimer's Disease Rat Model 33
Neural stem cells modified to express BDNF improve survival, neuronal differentiation and contribute to the resistance to TMT-induced neurotoxicity 33
The BRM chromatin-remodelling factor plays a specific role during muscle differentiation 33
Inhibition of retinoblastoma protein phosphorylation in terminally differentiated muscle cells 33
High Nitric Oxide Production, secondary to inducible-Nitrix Oxide Synthase expression, is Essential for Regulation of the Tumor-Initiating Properties of Colon Cancer Stem Cells 32
A binding site for the transcriptional repressor YY1/? is present in the polyomavirus late promoter 32
A comparative study of genetically modified rhNGF or rhBDNF-producing mouse neural stem cells 32
A CAAT box element supports CycinB1 promoter basal activity in proliferation C2C12 and mediates its downregulation during differentiation in vivo 32
Loss of NF-Y expression in terminally differentiated C2C12 cells, is cause of downregulation of CyclinB1 gene transcription 32
Meccanismo di induzione del promotore del gene Retinoblostoma da parte di MyoD 32
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 32
Common and rare genetic variants associated with Alzheimer's disease 31
Cholinergic and Dopaminergic Neuronal Differentiation of Human Adipose Tissue Derived Mesenchymal Stem Cells. 31
Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application 31
Ruolo della ciclina D3 nell'arresto del ciclo cellulare indotto da MyoD nel differenziamento muscolare. 31
Homo-translpantation of neural precursors into the rat hippocampus during TMT-induced neurodegenration 31
Pivotal Role of PDGFR alpha in anti-Notch1 and EGFR Resistant Cancer Stem Cells Derived from Peritumor Tissue of Glioblastoma Multiforme. 31
Human microbiome and its association with health and diseases 31
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27kip1 protein up-regulation and c-Myc mRNA down-regulation. 30
Cellule staminali neurali modificate geneticamente. La ricerca di oggi, le tecnologie del domani-Tecnologie per prevenzione, diagnosi e cura 30
Molecular Mechanism of hTid-1the HumanHomologof DrosophilaTumor Suppressor l(2)Tid in the Regulationof NF-B Activity 30
Relationships between MyoD and Rb1 in myogenesis. 30
MoyD induces retinoblastoma gene expression during myogenic differentiation 30
Totale 4.802
Categoria #
all - tutte 17.678
article - articoli 11.745
book - libri 542
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024392 0 0 0 0 0 0 0 0 26 11 14 341
2024/20251.917 19 6 136 78 456 136 36 139 57 66 435 353
2025/20262.530 143 250 210 404 415 138 392 117 149 145 77 90
2026/2027454 101 121 232 0 0 0 0 0 0 0 0 0
Totale 5.293